A three-phase population based sero-epidemiological study: Assessing the trend in prevalence of SARS-CoV-2 during COVID-19 pandemic in Jordan
Open Access
- 10 July 2021
- journal article
- research article
- Published by Elsevier BV in One Health
- Vol. 13, 100292
- https://doi.org/10.1016/j.onehlt.2021.100292
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Performance Characteristics of the Abbott Architect SARS-CoV-2 IgG Assay and Seroprevalence in Boise, IdahoJournal of Clinical Microbiology, 2020
- Estimating the burden of SARS-CoV-2 in FranceScience, 2020
- Serological tests facilitate identification of asymptomatic SARS‐CoV‐2 infection in Wuhan, ChinaJournal of Medical Virology, 2020
- Cumulative incidence and diagnosis of SARS-CoV-2 infection in New YorkAnnals of Epidemiology, 2020
- Seroprevalence of SARS-CoV-2–Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020JAMA, 2020
- Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based studyThe Lancet, 2020
- Interpreting Diagnostic Tests for SARS-CoV-2JAMA, 2020
- Association between age and clinical characteristics and outcomes of COVID-19European Respiratory Journal, 2020
- Coronavirus COV-19/SARS-CoV-2 affects women less than men: clinical response to viral infection.2020
- INDUCTION OF PRO-INFLAMMATORY CYTOKINES (IL-1 and IL-6) AND LUNG INFLAMMATION BY CORONAVIRUS-19 (COVI-19 or SARS-CoV-2): ANTI-INFLAMMATORY STRATEGIES2020